Ranked as the best nursing school in the world, Penn Nursing advances the entire profession, from research & education to practice & policy.
The undergraduate and transfer program uses hands-on, mentored education to transform what happens in the classroom to what happens in the clinical and beyond.
The accelerated program suits students with ambition to expedite their education in order to enter a chosen career path as soon as possible.
The masters program offers the opportunity to step to the forefront of nursing science and practice in a wide range of specialties.
Our doctoral programs are committed to producing leaders in the field of nursing science, both in scholarship and research (PhD) and clinical scholarship and practice (DNP).
Nancy A. Hodgson, PhD, RN, FAAN, the Anthony Buividas Term Chair in Gerontology and Professor of Nursing, will be the next chair of the University of Pennsylvania School of Nursing’s (Penn Nursing) Department of Biobehavioral Health Sciences (BHS), effective January 1, 2021.
The COVID-19 pandemic and the implications of physical distancing have disrupted new mothers’ birth and breastfeeding experiences even if they are not COVID-19 positive or a person awaiting results. In a new case series report from the University of Pennsylvania School of Nursing (Penn Nursing), researchers share common concerns and experiences as reported by three first-time, healthy mothers regarding the disruption of their birth plans and breastfeeding experiences.
Community immersion classes are central to teaching nursing students about social determinants of health. But what happens when on-site engagement is suspended due to a pandemic?
The Global Philadelphia Association uses the award to recognize international significant achievements of Philadelphia leaders in medicine and business entrepreneurship. Penn Nursing Dean Antonia Villarruel is one of five recipients to be honored this year during the virtual 2020 Globy Awards celebration on December 14, 2020.
Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show. Ironically, the significant advances in T1D therapeutics over recent years, especially new technologies, may have exacerbated racial disparities in diabetes treatment and outcomes.
Claire M. Fagin Hall
418 Curie Boulevard
Philadelphia, PA 19104-4217
Telephone: (215) 898-8281
Admissions: (215) 898-4271